Multiple Sclerosis Society of Canada

Frequently Asked Questions on the COVID-19 Vaccine: Children with Neuroinflammatory Conditions

Q: Should children who have had a single episode of neuroinflammation in the past get a COVID-19 vaccine?

A: Yes, all of the recommendations for people with MS apply to those who have had a single episode of neuroinflammation. There are no known special considerations for vaccination for people who have had a single episode of neuroinflammation in the past and who are not currently taking immunosuppressive medicine.

Q: How old does a child need to be to receive a COVID-19 vaccine?

A: The Pfizer-BioNTech COVID-19 vaccine has been tested in children age 12 years and older and can be administered in this age group. Clinical studies are currently underway in children younger than 12 and once they have been approved for administration in younger age groups, vaccination is recommended.

Q: Should children living with an allied condition such as Autoimmune Encephalitis, NMOSD or a MOG-related disorder and are taking immunosuppressive medications get vaccinated?

A: It is recommended that children living with an allied condition follow the MS Society guidelines in consultation with their healthcare provider with regards to timing of vaccination in relation to the specific treatments they are receiving.

Q: Should parents and siblings of children living with MS or allied condition get vaccinated?

A: It is recommended that all members of the same household receive a vaccine.

Open navigation